Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Some breast cancer chemotherapy can cause permanent hair loss.

Some chemotherapy can cause permanent hair loss.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New drug delivery methods can make natural compounds more effective and stable.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

CIP/KIP proteins help stop cell division and support hair growth.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.